Disruption of glucose homeostasis by bacterial infection orchestrates host innate immunity through NAD+/NADH balance
Jingjing Tang(Northwest A&F University), Lei Xu(U.S. National Science Foundation), Fuhua Zhang(South China Normal University), Xihui Shen(Northwest A&F University), Shukun Chen(University of Jinan), Yao Wang(South China Agricultural University), Mengyuan Li(University of Science and Technology Beijing), Lei Zhang(Zhengzhou University), Jianan Huang(Soochow University), Xiao Wang(Nanjing University), Yi Luo(Northwest A&F University), Jing Hou(Northwest A&F University), Tianyuan Chang(Northwest A&F University), Yanchao Gu(Northwest A&F University)
Cited by 39
Related Papers
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
|The Lancet Oncology|2011|4.1k
The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6/JAK/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer
|International Journal of Oncology|2016|385
Phase 2 study of pembrolizumab in advanced small-cell lung cancer (SCLC): KEYNOTE-158.
|Journal of Clinical Oncology|2018|208